0.1(top 100%)
impact factor
113(top 100%)
papers
226(top 50%)
citations
7(top 50%)
h-index
0.1(top 100%)
extended IF
139
all documents
248
doc citations
11(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Chapter 1 Principles of capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis199614
2Chapter 2 Statistical parameters and analytical figures of meritProgress in Pharmaceutical and Biomedical Analysis199612
3Chapter 6 Metabolite identification by lc-ms: applications in drug discovery and developmentProgress in Pharmaceutical and Biomedical Analysis200510
4Chapter 5 Capillary electrophoresis/Mass spectrometryProgress in Pharmaceutical and Biomedical Analysis19969
5Solid Phase Extraction for Sample PreparationProgress in Pharmaceutical and Biomedical Analysis19948
6Chapter 9 Quantification and structural elucidation of low quantities of radiolabeled metabolites using microplate scintillation counting (msc) techniques in conjunction with lc-msProgress in Pharmaceutical and Biomedical Analysis20058
72.7.5. HPLC/NMR and related hyphenated NMR methodsProgress in Pharmaceutical and Biomedical Analysis20007
82.7 High performance liquid chromatography (HPLC) and related techniquesProgress in Pharmaceutical and Biomedical Analysis20007
9Chapter 3 Electrokinetic chromatographyProgress in Pharmaceutical and Biomedical Analysis19966
102.10. Supercritical fluid chromatography (SFC)Progress in Pharmaceutical and Biomedical Analysis20006
112.9. Capillary electrochromatography (CEC)Progress in Pharmaceutical and Biomedical Analysis20005
126.4. Polarimetry, ORD and CD spectroscopyProgress in Pharmaceutical and Biomedical Analysis20005
13Chapter 10 Oxidative metabolites of drugs and xenobiotics: lc-ms methods to identify and characterize in biological matricesProgress in Pharmaceutical and Biomedical Analysis20055
14Chapter 11 Detection and characterization of highly polar metabolites by lc-ms: proper selection of lc column and use of stable isotope-labeled drug to study metabolism of ribavirin in ratsProgress in Pharmaceutical and Biomedical Analysis20055
15Development and Validation of Liquid Chromatographic Assays for the Regulatory Control of PharmaceuticalsProgress in Pharmaceutical and Biomedical Analysis19945
16A Comprehensive Method Validation Strategy for Bioanalytical Applications in the Pharmaceutical IndustryProgress in Pharmaceutical and Biomedical Analysis19945
172.7 High performance liquid chromatography (HPLC) and related techniquesProgress in Pharmaceutical and Biomedical Analysis20004
182.4. NMR spectroscopyProgress in Pharmaceutical and Biomedical Analysis20004
19Chapter 9 Liquid-liquid extraction: Strategies for method development and optimizationProgress in Pharmaceutical and Biomedical Analysis20034
20Chapter 10 Separation of nucleic acids and oligonucleotides and sequencing of DNA Fragments by capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis19963
211.2 The nature and origin of the impurities in drug substancesProgress in Pharmaceutical and Biomedical Analysis20003
221.1. Introductory remarksProgress in Pharmaceutical and Biomedical Analysis20003
232.7 High performance liquid chromatography (HPLC) and related techniquesProgress in Pharmaceutical and Biomedical Analysis20003
241.3. Toxicological aspectsProgress in Pharmaceutical and Biomedical Analysis20003
252.8. Determination of drug related impurities by capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis20003
262.1. Strategies in impurity profilingProgress in Pharmaceutical and Biomedical Analysis20003
27Chapter 3 Commonly encountered analytical problems and their solutions in liquid chromatography/ tandem mass spectrometry (LC/MS/MS) methods used in drug developmentProgress in Pharmaceutical and Biomedical Analysis20053
28On-Line Microdialysis SamplingProgress in Pharmaceutical and Biomedical Analysis19943
29Chapter 7 Sample preparation for capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis19962
30Chapter 9 Capillary electrophoresis of proteins and peptidesProgress in Pharmaceutical and Biomedical Analysis19962
312.3. Mass spectrometry in impurity profilingProgress in Pharmaceutical and Biomedical Analysis20002
322.5. Planar chromatographyProgress in Pharmaceutical and Biomedical Analysis20002
331.5. Regulatory aspects: ICH and pharmacopoeial perspectivesProgress in Pharmaceutical and Biomedical Analysis20002
341.4. The role of impurity profiling in drug research, development and productionProgress in Pharmaceutical and Biomedical Analysis20002
352.9. Capillary electrochromatography (CEC)Progress in Pharmaceutical and Biomedical Analysis20002
369.4. SteroidsProgress in Pharmaceutical and Biomedical Analysis20002
37Chapter 6 Protein precipitation: High throughput techniques and strategies for method developmentProgress in Pharmaceutical and Biomedical Analysis20032
38Chapter 2 Fundamental strategies for bioanalytical sample preparationProgress in Pharmaceutical and Biomedical Analysis20032
39Chapter 5 In vitro dmpk screening in drug discovery, role of lc-ms/msProgress in Pharmaceutical and Biomedical Analysis20052
40Chapter 2 Strategies for increasing throughput for pk samples in a drug discovery environmentProgress in Pharmaceutical and Biomedical Analysis20052
41Chapter 12 Cytochrome p450 (cyp) and udp-glucuronosyltransferase (ugt) enzymes: role in drug metabolism, polymorphism, and identification of their involvement in drug metabolismProgress in Pharmaceutical and Biomedical Analysis20052
42Pharmaceutical and Biomedical Applications of Capillary ElectrophoresisProgress in Pharmaceutical and Biomedical Analysis19942
43Novel Approaches to the Liquid Chromatographic Analysis of Primary Amines, Amino Acids and PeptidesProgress in Pharmaceutical and Biomedical Analysis19942
44Multi-column Approaches to Chiral Bioanalysis by Liquid ChromatographyProgress in Pharmaceutical and Biomedical Analysis19942
45Chapter 9 Biotechnology productsProgress in Pharmaceutical and Biomedical Analysis19961
46Chapter 11 Analytical methods for cleaning proceduresProgress in Pharmaceutical and Biomedical Analysis19961
47Chapter 2 Column technologies for capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis19961
48Chapter 4 Optical detection strategies in capillary electrophoresisProgress in Pharmaceutical and Biomedical Analysis19961
49Chapter 12 Capillary electrophoresis-based methods for in vivo analysis: Single cell analysis and microdialysis samplingProgress in Pharmaceutical and Biomedical Analysis19961
50Chapter 4 Issues related to the United States v. Barr Laboratories, Inc.Progress in Pharmaceutical and Biomedical Analysis19961